Literature DB >> 21445699

Progressive multifocal leukoencephalopathy in an HIV patient receiving successful long-term HAART.

Marta Mascarello1, Massimiliano Lanzafame, Emanuela Lattuada, Ercole Concia, Sergio Ferrari.   

Abstract

Progressive multifocal leukoencephalopathy (PML) has been traditionally associated to severe immunosuppression and described mainly in highly active antiretroviral therapy (HAART)-naïve patients with a low lymphocyte CD4+ count. In the last years, some cases of PML have been described in HIV patients with a higher CD4+ count shortly after initiation of HAART and in association with the immune reconstitution inflammatory syndrome (IRIS). We report on a rare case of PML, not IRIS associated, that occurred in a HIV-positive patient with a lymphocyte CD4+ count greater than 700/µl and with an undetectable HIV viral load resulting from a long-term HAART. We describe the pathological and the ultrastructural features of the brain lesion. This case confirms that a severe immunosuppression or an IRIS is not required for the development of PML in HIV positives. The diagnosis of PML should always be considered in patients with consistent neurological symptoms, even with a high lymphocyte CD4+ level and a full viral suppression resulting from a long-term HAART.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21445699     DOI: 10.1007/s13365-011-0020-y

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  13 in total

Review 1.  The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature.

Authors:  Paola Cinque; Simona Bossolasco; Anna Maria Brambilla; Antonio Boschini; Cristina Mussini; Chiara Pierotti; Adriana Campi; Salvatore Casari; Davide Bertelli; Maurizio Mena; Adriano Lazzarin
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

Review 2.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

3.  Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.

Authors:  W Tantisiriwat; P Tebas; D B Clifford; W G Powderly; C J Fichtenbaum
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

4.  HIV-associated PML presenting as epilepsia partialis continua.

Authors:  S Ferrari; S Monaco; M Morbin; G Zanusso; L Bertolasi; R Cerini; N Rizzuto
Journal:  J Neurol Sci       Date:  1998-12-11       Impact factor: 3.181

Review 5.  Progressive multifocal leukoencephalopathy in HIV-1 infection.

Authors:  Paola Cinque; Igor J Koralnik; Simonetta Gerevini; Jose M Miro; Richard W Price
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

6.  JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.

Authors:  Nina Khanna; Marcel Wolbers; Nicolas J Mueller; Christian Garzoni; Renaud A Du Pasquier; Christoph A Fux; Pietro Vernazza; Enos Bernasconi; Raphael Viscidi; Manuel Battegay; Hans H Hirsch
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 7.  Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.

Authors:  Sarah Gheuens; Gerald Pierone; Patrick Peeters; Igor J Koralnik
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10-14       Impact factor: 10.154

8.  PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy.

Authors:  P Ferrante; R Caldarelli-Stefano; E Omodeo-Zorini; L Vago; R Boldorini; G Costanzi
Journal:  J Med Virol       Date:  1995-11       Impact factor: 2.327

9.  Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.

Authors:  Nina Khanna; Luigia Elzi; Nicolas J Mueller; Christian Garzoni; Matthias Cavassini; Christoph A Fux; Pietro Vernazza; Enos Bernasconi; Manuel Battegay; Hans H Hirsch
Journal:  Clin Infect Dis       Date:  2009-05-15       Impact factor: 9.079

10.  A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

Authors:  Renaud A Du Pasquier; Marcelo J Kuroda; Yue Zheng; Jims Jean-Jacques; Norman L Letvin; Igor J Koralnik
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

View more
  4 in total

1.  Ataxia and HIV: clinicopathologic correlations in a case of HIV-associated cerebellar leukoencephalopathy.

Authors:  Christos Ganos; Christian Bernreuther; Jakob Matschke; Christian Gerloff; Alexander Münchau; Frank Leypoldt
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

Review 2.  Treatment-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Comprehensive Review of Current Evidence and Future Needs.

Authors:  Emanuele D'Amico; Aurora Zanghì; Carmela Leone; Hayrettin Tumani; Francesco Patti
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

3.  HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.

Authors:  Marco Iannetta; Anna Bellizzi; Sara Lo Menzo; Elena Anzivino; Alessandra D'Abramo; Alessandra Oliva; Claudia D'Agostino; Gabriella d'Ettorre; Valeria Pietropaolo; Vincenzo Vullo; Maria Rosa Ciardi
Journal:  J Neurovirol       Date:  2013-05-29       Impact factor: 2.643

Review 4.  Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders.

Authors:  Han Liu; Enquan Xu; Jianuo Liu; Huangui Xiong
Journal:  Brain Sci       Date:  2016-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.